

Unrealized gains (losses) on available-for-sale securities, net See Note 9 to consolidated financial statements for further discussion.ĬONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (2) Includes interest expense of consolidated VIEs of $50,193 and $42,491 for the quarters ended Jand March 31, 2022, respectively, and $92,684 and $116,141 for the six months ended Jand 2021, respectively. See Note 9 to consolidated financial statements for further discussion. (1) Includes interest income of consolidated VIEs of $140,209 and $131,066 for the quarters ended Jand March 31, 2022, respectively, and $271,275 and $307,214 for the six months ended Jand 2021, respectively. Weighted average number of common shares outstanding:ĭividends declared per share of common stock Net income (loss) per share available to common shareholders:

Net income (loss) available to common shareholders

Net realized gains (losses) on sales of investments Net unrealized gains (losses) on financial instruments at fair value Net unrealized gains (losses) on derivatives Increase (decrease) in provision for credit losses As of June 30, 2022, and December 31, 2021, total assets of consolidated VIEs were $10,783,461 and $10,666,591, respectively, and total liabilities of consolidated VIEs were $7,293,599 and $7,223,655, respectively. (1) The Company's consolidated statements of financial condition include assets of consolidated variable interest entities, or VIEs, that can only be used to settle obligations and liabilities of the VIE for which creditors do not have recourse to the primary beneficiary (Chimera Investment Corporation). Total liabilities and stockholders' equity
#Chimera securities series#
Preferred Stock, par value of $0.01 per share, 100,000,000 shares authorized:Ĩ.00% Series A cumulative redeemable: 5,800,000 shares issued and outstanding, respectively ($145,000 liquidation preference)Ĩ.00% Series B cumulative redeemable: 13,000,000 shares issued and outstanding, respectively ($325,000 liquidation preference)ħ.75% Series C cumulative redeemable: 10,400,000 shares issued and outstanding, respectively ($260,000 liquidation preference)Ĩ.00% Series D cumulative redeemable: 8,000,000 shares issued and outstanding, respectively ($200,000 liquidation preference)Ĭommon stock: par value $0.01 per share 500,000,000 shares authorized, 231,748,414 and 236,951,266 shares issued and outstanding, respectively Securitized debt at fair value, collateralized by Loans held for investment ($11.1 billion and $11.0 billion pledged as collateral, respectively) Securitized debt, collateralized by Non-Agency RMBS ($309 million and $365 million pledged as collateral, respectively) Secured financing agreements ($4.0 billion and $4.4 billion pledged as collateral, respectively) Non-Agency RMBS, at fair value (net of allowance for credit losses of $5 million and $213 thousand, respectively) (dollars in thousands, except share and per share data) Chimera also repurchased 5.4 million shares of its common stock over the period, which is accretive to our earnings available for distribution."ĬONSOLIDATED STATEMENTS OF FINANCIAL CONDITION "Securitizations and secured financing agreements provide stable, long-term financing for Chimera's credit assets. "Despite the challenging market environment of higher interest rates and wider credit spreads, Chimera remained committed to effectively and efficiently managing its liquidity, liabilities and capital structure during the quarter," said Mohit Marria, CEO and Chief Investment Officer. Earnings available for distribution (1) for the second quarter ended Jwas $74 million, or $0.31 per diluted common share. The Company’s GAAP net loss for the second quarter was $180 million, or $0.76 per diluted common share. NEW YORK, August 04, 2022-( BUSINESS WIRE)-Chimera Investment Corporation (NYSE:CIM) today announced its financial results for the second quarter ended June 30, 2022. GAAP BOOK VALUE OF $8.82 PER COMMON SHARE 2ND QUARTER GAAP NET LOSS OF $0.76 PER DILUTED COMMON SHAREĢND QUARTER EARNINGS AVAILABLE FOR DISTRIBUTION (1) OF $0.31 PER DILUTED COMMON SHARE.
